NCT02872883

Brief Summary

This is a pilot study that will eventually result in a main randomised controlled trial that will look at what management is associated with a higher rate of normal birth and a lower rate of chorioamnionitis (maternal infection) when women break their waters but labour does not start. Spontaneous rupture of the membranes (when the waters break) at term (37-42 weeks gestation) is a physiological event that happens during labour. However, according to Gunn et al. (1970) in 8-10 % of the cases the membranes rupture before labour starts. The time between the rupture and the onset of labour is called latent phase and time wise is variable. Studies have showed no statistically significant differences in terms of neonatal infection or chorioamnionitis when the investigators induce labour with prostaglandins compared to when labour starts spontaneously (Hannah et al 1996). Seaward et al. (1997) noted a number of confounding factors that might relate to the incidence of chorioamnionitis (maternal infection), the strongest predictor was having more than 8 vaginal examinations since the rupture of membranes and before delivery which was a stronger predictor than the duration of the latent phase. It is thought that by reducing the number of internal examinations, chorioamnionitis may be reduced, and hence neonatal infection may also be reduced. The main RCT will compare clinical outcomes and maternal satisfaction when women consent to be randomized to four groups: (1) Active management and routine internal examinations during labour, (2) Active management and reduced internal examinations, (3) Expectant management and routine internal examinations, (4) Expectant management and reduced internal examinations. This application seeks ethics approval for the pilot phase to ensure that a definitive study can be undertaken appropriately. It is important to test that all the components work well individually and as a whole, to estimate sample size and ultimately to test the integrity of the research protocol before embarking on the main trial.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2016

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 14, 2016

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 19, 2016

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2016

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2017

Completed
Last Updated

November 16, 2016

Status Verified

November 1, 2016

Enrollment Period

11 months

First QC Date

July 14, 2016

Last Update Submit

November 14, 2016

Conditions

Keywords

Prelabour rupture of membranesterm pregnancymanagementvaginal examinationinduction of labourexpectant management

Outcome Measures

Primary Outcomes (1)

  • Percentage of eligible women who agree to take part in the study

    12 months during pilot stage

Secondary Outcomes (2)

  • Percentage of participants who stay in the allocation arm

    12 months during pilot stage

  • Percentage of participants who find the interventions acceptable

    The questionnaire will be completed by the participants between 4-8 weeks after giving birth

Study Arms (4)

Expectant management and minimal vaginal examinations

EXPERIMENTAL

Expectant management up to approximately 96hours and vaginal examinations only when necessary during active labour

Procedure: Expectant managementProcedure: Minimal Vaginal examinations (only when necessary)

Expectant management and routine vaginal examinations

EXPERIMENTAL

Expectant management up to approximately 96hours and routine vaginal examinations during active labour

Procedure: Expectant managementProcedure: Routine vaginal examinations

Active management and minimal vaginal examinations

EXPERIMENTAL

Induction of labour at approximately 24hours and vaginal examinations only when necessary during active labour

Procedure: Minimal Vaginal examinations (only when necessary)Procedure: Active management

Active management and routine vaginal examinations

ACTIVE COMPARATOR

Induction of labour at approximately 24hours and routine vaginal examinations

Procedure: Active managementProcedure: Routine vaginal examinations

Interventions

Expectant management and minimal vaginal examinationsExpectant management and routine vaginal examinations
Active management and minimal vaginal examinationsExpectant management and minimal vaginal examinations
Active management and minimal vaginal examinationsActive management and routine vaginal examinations
Active management and routine vaginal examinationsExpectant management and routine vaginal examinations

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Prelabour rupture of membranes (confirmed)
  • Term pregnancy - from 37+0 till 41+2 weeks gestation (both inclusive)
  • Normal/Low risk pregnancy
  • Singleton, cephalic pregnancy
  • No known current infectious diseases
  • Aged 18-45 years old
  • Understands English and is able to read and write in English
  • Agree for their placentas to be sent to histology if clinical signs of infection
  • Not taking part in other clinical research at present
  • Consent to take part

You may not qualify if:

  • Pregnancy of 36+6 or less or 41+3 or more weeks gestation
  • Breech or oblique presentation
  • Twin or multiple pregnancy
  • Previous caesarean section
  • Meconium stained liquor
  • Pre-eclampsia
  • Diabetes
  • Known to be colonised by Group B streptococcus
  • Current infections: HIV, Hepatitis B, Herpes
  • Doesn't give consent for the placenta to be sent to histology if clinical signs of infection
  • Not able to understand, read or write in English
  • Currently taking part in other clinical research

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lancashire Teaching Hospitals NHS Trust

Preston, Lancashire, United Kingdom

RECRUITING

MeSH Terms

Interventions

Watchful Waiting

Intervention Hierarchy (Ancestors)

Outcome Assessment, Health CareOutcome and Process Assessment, Health CareQuality of Health CareHealth Services Administration

Study Officials

  • Lucia Ramirez-Montesinos, MSc BSc

    University of Central Lancashire

    PRINCIPAL INVESTIGATOR
  • Soo Downe, PhD MSc BSc

    University of Central Lancashire

    STUDY DIRECTOR

Central Study Contacts

Lucia Ramirez-Montesinos, MSc BSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Miss

Study Record Dates

First Submitted

July 14, 2016

First Posted

August 19, 2016

Study Start

November 1, 2016

Primary Completion

October 1, 2017

Study Completion

November 1, 2017

Last Updated

November 16, 2016

Record last verified: 2016-11

Data Sharing

IPD Sharing
Will not share

Locations